Clinical Trial Detail

NCT ID NCT02400242
Title Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acetylon Pharmaceuticals Incorporated
Indications

multiple myeloma

Therapies

Citarinostat

Dexamethasone

Pomalidomide

Age Groups: adult

No variant requirements are available.